tirzepatide legal battle Eli Lilly enters with another weight-loss drug manufacturer Compounders lose battle over Eli

Secondary analyses revealed that visceral fat reduction on tirzepatide occurred earlier than total weight loss stabilized

For individuals with severe obesity (BMI over 40), higher doses of GLP-1 agonists may be required, but these come with a greater risk of side effects

This can help prevent your stomach from getting too full and give your digestive system an easier time

This makes our lips even drier and more vulnerable to the environment

CrossRef Letter to the Editor concerning The diabetic shoulder: association between diabetes mellitus and adhesive capsulitis a systematic review and meta-analysis Zhongliao Zeng, Jinkun Li, zechen zhang, Xiaolin Shi, Yifeng Yuan International Orthopaedics.2026